LRRK2 and Parkinson disease: The association between PD and cancer was supported by the genetic mutations of SNCA, PARK2 and PARK8, ATM, p53, PTEN and MC1R resulting in mitochondrial dysfunction, aberrant protein aggregation and cell cycle dysregulation [273].